Selective disruption of miR-31–5p/CTR-mRNA binding reversed atrial fibrosis and decreased AF burden in vivo in a clinically relevant model of progressive atrial fibrosis and arrhythmia. The gene discussed is CALCR; the disease is Arrhythmia.